Veracyte Acquires Allegro Diagnostics for $21,000,000

  • Feed Type
  • Date
    9/5/2014
  • Company Name
    Allegro Diagnostics
  • Mailing Address
    6 Clock Tower Place Maynard, MA 01754 USA
  • Company Description
    Allegro Diagnostics is a leader in the field of gene expression molecular diagnostic testing for lung cancer and other diseases.
  • Website
    http://www.allegrodx.com
  • Transaction Type
    M&A
  • Transaction Amount
    $21,000,000
  • Transaction Round
  • Proceeds Purposes
  • M&A Terms
    The purchase price is comprised of $7.8 million in cash and $13.2 million in Veracyte common stock.